Coinstar gave some 4Q guidance late yesterday that was disappointing. CEO Paul Davis admits the company made a couple demand miscalculations and experienced inventory management issues within the quarter. Shares fell 24% after hours Thursday. Sanofi Aventis and Genzyme – Sanofi is trying to broker a deal to buy Genzyme for $76 per share. Google getting hit from all sides today. The search-giant’s $700M acquisition of travel software company, ITA is being challenged by the U.S. government. The Justice Department is looking into antitrust issues concerning that deal, while in South Korea the site is accused of breaking federal laws with it’s Street View mapping application. Also use caution around Citigroup stock today, the TARP Special Inspector General Neil Barofsky said in a report yesterday that it’ s 2008 bailout was ‘ad-hoc’. He says there is serious ‘moral hazard associated with the continued existence of institutions that remain ‘too big to fail’. So keep your eye on the financials on Friday. Finally, the last stock to look out for today, Intel may see a boost. The tech-company had beat the street’s earnings expectations late yesterday. Intel put out it’s best quarterly and yearly results ever and made an optimistic forecast for the year ahead, projecting 10% increase in revenue in 2011 versus 2010. Shares went up 2% in after hours trade. We interviewed Mahesh Sanganeria from RBC Capital Markets so make sure you watch that clip on Intel earnings for further detail on the stock.<\/p>\n","protected":false},"excerpt":{"rendered":"
Coinstar gave some 4Q guidance late yesterday that was disappointing. CEO Paul Davis admits the company made a couple demand miscalculations and experienced inventory management issues within the quarter. Shares fell 24% after hours Thursday. Sanofi Aventis and Genzyme – Sanofi is trying to broker a deal to buy Genzyme for $76 per share. Google … <\/p>\n